1. Home
  2. CHEF vs MESO Comparison

CHEF vs MESO Comparison

Compare CHEF & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEF
  • MESO
  • Stock Information
  • Founded
  • CHEF 1985
  • MESO 2004
  • Country
  • CHEF United States
  • MESO Australia
  • Employees
  • CHEF N/A
  • MESO N/A
  • Industry
  • CHEF Food Distributors
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CHEF Consumer Discretionary
  • MESO Health Care
  • Exchange
  • CHEF Nasdaq
  • MESO Nasdaq
  • Market Cap
  • CHEF 2.0B
  • MESO 1.7B
  • IPO Year
  • CHEF 2011
  • MESO N/A
  • Fundamental
  • Price
  • CHEF $53.70
  • MESO $10.72
  • Analyst Decision
  • CHEF Strong Buy
  • MESO Buy
  • Analyst Count
  • CHEF 6
  • MESO 4
  • Target Price
  • CHEF $66.00
  • MESO $18.00
  • AVG Volume (30 Days)
  • CHEF 500.4K
  • MESO 240.4K
  • Earning Date
  • CHEF 04-30-2025
  • MESO 02-26-2025
  • Dividend Yield
  • CHEF N/A
  • MESO N/A
  • EPS Growth
  • CHEF 50.69
  • MESO N/A
  • EPS
  • CHEF 1.32
  • MESO N/A
  • Revenue
  • CHEF $3,794,212,000.00
  • MESO $5,670,000.00
  • Revenue This Year
  • CHEF $8.01
  • MESO $228.57
  • Revenue Next Year
  • CHEF $7.37
  • MESO $356.77
  • P/E Ratio
  • CHEF $40.67
  • MESO N/A
  • Revenue Growth
  • CHEF 10.50
  • MESO N/A
  • 52 Week Low
  • CHEF $31.96
  • MESO $4.60
  • 52 Week High
  • CHEF $66.51
  • MESO $22.00
  • Technical
  • Relative Strength Index (RSI)
  • CHEF 50.44
  • MESO 38.38
  • Support Level
  • CHEF $52.26
  • MESO $10.26
  • Resistance Level
  • CHEF $55.17
  • MESO $11.33
  • Average True Range (ATR)
  • CHEF 2.70
  • MESO 0.75
  • MACD
  • CHEF 0.36
  • MESO 0.06
  • Stochastic Oscillator
  • CHEF 78.45
  • MESO 37.37

About CHEF The Chefs' Warehouse Inc.

The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. It operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, midwest, and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos, and specialty food stores.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: